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Introduction
The growing burden of chronic disease of civilization
during the 20th century and at the beginning of the 21st
century in the context of demographic change, health pro-
motion and treatment, is becoming a dominant agenda of the
process of health policy making according to World Health
Organization (WHO). Cerebrovascular disease (CVD) is not
only the world's second leading cause of death, but also an
important factor causing the reduction of self-sufficiency of
chronically ill in both developing and developed countries 
1.
The first half of the 90s, thanks to the work of the Harvard
School of Public Health and its application by the WHO,
brought about a new comprehensive framework for the
evaluation of morbidity, mortality and also self-sufficiency
of chronically ill called “Burden of disease” (or “disease
burden”) 
2.
The new combination of years of life lost due to pre-
mature death  and years of life lived in less than full health.
CVD represents an illness which leads to an average of
9.3 years lost due to premature death or disability in devel-
oped countries 
2. In comparison with other diseases, CVD
has one of the major socioeconomic and health impacts on
society. The concept of the Disease Burden (DALYs) with-
out doubt becomes the basis of the new approach to the for-
mulation of health policy priorities, both in the field of medi-
cine and health promotion 
1.
The question is how, in the current practice of the
Czech health policy discussions, we manage to orientate the
action of risk groups, patients and doctors to the control of
risk factors on one hand, and to the treatment of acute stroke
and particularly the care about chronically ill patients after
acute phase (if the model of care about chronically ill is effi-
cient) on the other one.
International trends in morbidity and mortality
from cerebrovascular disease
Research on the incidence, prevalence and mortality of
stroke is based on a various data sources (hospital´s patients
database, data from the acute care, demographic data on spe-
cific mortality, epidemiological studies) 
3–11. Opportunities
for the comparison of these data are complicated by meth-
odological differences, diversely defined age groups, but also
by the uncertainty about the reliability of the diagnosis with
the definition of stroke by the WHO 
12. The need for the reli-
ability and consistency of methodologies, including age-
standardized data, arise especially when we want to observe
the long-term developmental changes 
7. Current epidemiol-
ogical values of age-standardized incidence of stroke for
people younger than 55 years, range from 4.2 to 11.7 per
thousand per year (Figure 1). Actual values show significant
differences depending on the observed territorial units. The
average age of patients with stroke is about 70 years for men
and about 75 years for women. More than half of the cases of
stroke occur at the age below 75 years 
7.
While in younger age groups we can observe the de-
cline of emergence of CVD, in older age groups there is a
stabilization or increase in the incidence. Differences (varia-
tion in the incidence, prevalence and mortality) are also ob-Volumen 69, Broj 9 VOJNOSANITETSKI PREGLED Strana 795
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served in accordance to the ethnicity of specific groups,
where we can see also the similarities in the policies of pre-
vention, but also in their economic conditions. As the deter-
minants of these differences, we can consider the quality of
the acute care and the prevention of risk factors 
6.
Fig. 1 – Standardized specific cerebrovascular disease
(CVD) mortality in all age-groups – comparison of the Czech
Republic (CR) and EU15 (before accession)
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The publications of the Center for Disease Control in
the USA are a global perspective on the development of the
overall burden of disease of CVD, including the review of
the situation on the level of effectiveness of risk factors con-
trol 
13. The data (large correlation maps appended with
graphs) are available on the WHO site 
12. The values of the
years of life lost due to premature death or due to disability
(measured by the index DALYs) range in the North America
and Western Europe below 5. The values for the Central and
Eastern Europe along with the values for the countries of
North Africa vary from 5 to 9. The worst situation is in Rus-
sia and in some Central Asian states like Kazakhstan (values
greater than 15). The values from 10 to 14 are found in Af-
rica and South America, China and India 
14. A global ap-
proach to the differences in morbidity and their determinants
have become an important stimulus for research and formu-
lation of strategies focused on the solution of these problems.
In the context of demographic change in developed countries
and under the existing conditions of combined risk factors,
we can expect the increase in the number of diseases in the
group of CVD.
The EUSI Report (2003) 
15 states that the main causes
of disability (of DALYs), for men aged 49–69 are tuberculo-
sis (TBC) at the first place with a value of 9.3, then coronary
heart disease (CHD) with 7.6 and CVD with 6.7. At the age
over 60 years, CVD is the first cause (13.8), at the second
place is CHD with 11.7 and at the third place is chronic ob-
structive pulmonary disease (CHOPD) with 9.6.
For women, stroke is the main cause of DALYs in both
age groups: age 49–69 years: 1. CVD (8.7), 2. TBC (5.6), 3.
CHD (4.7); age over 60 years: 1. CVD (16.5), 2. CHD
(11.6), 3. CHOBPN (8.1).
Taking into account the available data, partial studies
and review articles, it is clear that the importance of the epi-
demiology of stroke was more underestimated in the past in
comparison with controlled clinical experiments. Disparities
in the methodological approaches lead to the need for greater
attention to this issue within the neurological community. An
example of this approach is the publication of Feigin and
Bennett in 2007 
7.
Mortality and morbidity from cerebrovascular
disease in the Czech Republic
In the Czech Republic (CR) the accurate epidemiol-
ogical data on stroke are missing. The value of mortality on
stroke in the population aged under 65 years doubled in
comparison with the countries of Western and Northern
Europe, with a maximum values for men in the category of
45–65 years (National Cerebrovascular Program). In the
upcoming decades the increase in the incidence of stroke is
expected, due to the increase of the percentage of elderly
population (in Europe it is expected that the elderly would
represent about 30% of the population). But the charts of
the development of specific stroke mortality in the CR in
comparison with EU15 shows that the trend of future de-
velopment is promising. The CR has the opportunity to
reach the level of developed European countries in 2015
(Figure 2) 
4, 16, 17.
Fig. 2 – Standardized specific cerebrovascular disease
(CVD) mortality in the age-group 0–64 years – comparison
of the Czech Republic (CR) and EU15 (before accession)
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The development of standardized mortality of cerebro-
vascular and coronary heart disease in the CR during the 90s
was favorable in both the age group from 0 to 64 years, and
in all age groups with the exception of the standardized
mortality rate for cerebrovascular disease in all age groups in
2000–2005, when there was a significant decrease in the sus-Strana 796 VOJNOSANITETSKI PREGLED Volumen 69, Broj 9
Jaganjacova D, et al. Vojnosanit Pregl 2012; 69(9): 794–798.
pension of the decline of mortality and thereby a “delay” in
the process of achieving the EU15 level. A vulnerable group
includes in this case patients older than 64 years. The ques-
tion is what factors participate in this problematic difference
in mortality in the CR in comparison with developed EU
countries 
16.
Strategy for prevention and treatment of stroke
Strategy for prevention and treatment of CVD is dis-
cussed internationally within several scientific disciplines,
which are primarily focused on different subjects. Medical
disciplines such as neurology and cardiology and the corre-
sponding professional society in the US, Europe or in CR
formulated in the last 20 years a number of recommendations
(guidelines) to which are subsequently incorporated new re-
search findings. In the US the synthesis of recommended
procedures for treatment and prevention of stroke is available
freely on the Internet 
18. Since the early 90's some parts of
these recommendations have been published in Stroke jour-
nal. It is a joint production of professional cardiological soci-
ety (American Heart Association – AHA) and professional
society for stroke (American Stroke Association – ASA).
The volume of financial resources in this area clearly ex-
ceeds the resources spent in Europe and that is what also de-
termines the difference in the production of new findings. In
the US, the tradition of research on health services is more
open than for example in the CR and the results are com-
monly used for further upgrade of health care provision.
The European strategy of CVD treatment has been the
subject of quite intensive professional discourse since the
early 90´s, which has been repeatedly summarized 
19. Rela-
tively detailed informations about this development are
regularly published in the journal Cerebrovascular Diseases.
Helsingborg declarations 
20 arose on the basis of consensus,
roofed by the WHO. The Declaration of 2006 is divided into
five main areas (organization of care for patients with stroke,
acute care management, prevention, rehabilitation after
stroke, evaluation of achievements and quality). Helsingborg
declaration of 2006 sets out the objectives for Europe till
2015. These goals apply to all patients after CVD. However
this declaration does not contain direct links to the publica-
tions in professional journals and books so the targets rather
show the direction of useful action. The representatives of pa-
tients were also involved in the process of creation of the decla-
ration. Taking into account the need of multidisciplinary ap-
proach, the “roof making strategy” of the WHO creates an im-
portant opportunity for mutual meetings of both the representa-
tives of the medical disciplines and of public health and health
promotion. From the formulations in the Helsingborg Declara-
tion it is clear that there exists an opportunity for cooperation of
multiple disciplines, the cooperation that may lead to a signifi-
cant reduction in burden of CVD.
In Europe, more detailed information how to deal with
stroke are the subject of Guidelines for Management of Is-
chaemic Stroke and Transient Ischaemic Attack. This
document was formulated by the European Stroke Initia-
tive. We can compare this activity to the American AHA
and ASA. The European recommendations for the treat-
ment of stroke are formulated on 80 pages and accompa-
nied by a list of about 400 scientific references. In this re-
spect it is comparable to the production in the US, but it is
clear that in the US the relevant documents are not only
larger and more numerous, but also supported by more de-
tailed arguments. It is interesting that in the document of
the European Stroke Strategies (ESO) 2009 there is the in-
tention of harmonization of the treatment and prevention of
CVD recommendations of the WHO, ESO and national in-
stitutions is declared.
Compared with the two above-mentioned approaches,
the situation in the CR is more modest. On the site of the
Cerebrovascular Section of the Neurological Society of JEP
(Czech Medical Society of Jan Evangelista PurkynČ) the Na-
tional Cerebrovascular Program is available, which is not,
however, defined in terms of time. We can only expect that it
was created in 2003, because it refers to the Helsingborg
Declaration of 1995 and there are no references to the Euro-
pean Stroke Initiative in 2008. This document does not con-
tain links to literature and its attachments are not accessible
for the public user. There is no indication if the presented
data are age-standardized or not so the validity of the even-
tual international comparison is doubtful.
Professional discourse concludes that in this area there
are relatively adequate knowledge resources, including the
availability of required data. The problem and challenge is
still a difference in the level of quality, organization and ac-
cessibility of health services, or activities in health promo-
tion (according to the MONIKA research
 21, the CR does not
manage to control the risk factors, which could be seen as a
deficit and a challenge).
A key task of the future strategy for Europe is to resolve
how we could reduce the health gaps between countries. Pa-
tients with stroke should be treated in specialized centers
with stroke units (Stroke Unit Trialists Collaboration, 1997).
Minimum requirements of such centers include continuous
availability of CT (X-ray computed tomography), the pres-
ence of neurologists and other physicians able to treat these
patients, the presence of professional staff and adherence to
guidelines for providing care and treatment. Centers and
units for such patients are not the only prerequisite for the
treatment of patients with stroke. The optimal functioning of
the whole system is possible only on the basis of available,
well-established and functioning network, which would sent
patients to subsequent specialized centers and rehabilitative
facilities. The collaboration with general practitioners in the
fields of primary and secondary prevention is an apparent
condition. If the care should be optimal, it is absolutely es-
sential that all the patients with stroke are immediately trans-
ported to hospital which can provide adequate care. The pa-
tients benefit most from the care on stroke units. Patients in
critical condition must be placed onto the resuscitation unit
(European Ad Hoc Consensus Group, 1997). The recom-
mendations of the Stroke Council of the American Heart As-
sociation and the European Ad Hoc Group Consensus imply
that in the acute phase of stroke, it is necessary to sort pa-
tients according to their clinical condition.Volumen 69, Broj 9 VOJNOSANITETSKI PREGLED Strana 797
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Situation in the Czech Republic, the existing
problems in organization in stroke care
Organization of care for patients with cerebrovascular
diseasis regulated Bulletin No. 2/2010 of the Ministry of
Health of the Czech Republic. The Bulletin provides mate-
rial, technical and staffing complex of cerebrovascular stroke
centers and centers that make network of devices that are
able to provide acute and follow-up care to patients with
cerebral vascular events. The reason for the existence of a
network of healthcare facilities – complex cerebrovascular
centers (KCC) and stroke centers (IC) is that from January 1,
2011 it is a necessity that all patients with acute stroke are
transported to the nearest medical facility (IC KCC), which
meets the personal and material conditions for the provision
of acute and subsequent treatment. The network is designed
on the principle of availability of acute recanalized therapy
(systemic thrombolysis or endovascular therapy) within the
IC or the KCC indicated for each patient with stroke. Ac-
cording to the experts, only the strict centralization of acute
care with a concentration of trained personnel and material
conditions will achieve an increase in percentage of patients
treated with systemic intravenous thrombolysis in the acute
stage of cerebral infarction. In 2007, in the Czech Republic,
only 4,3% of all patients with ischemic stroke were
treated 
22.
For the survey of care organization, we chose the case
method in which we created and  used questionnaires for the
patients. At the beginning of the questionnaire the informed
consent was included of the interviewed citizen. The first
part of the questionnaire consists of basic information about
the person, education, work activities, social and economic
determinants of health. The second part contains personal
and family risk factors involved in stroke disease. The third
part relates to lifestyle and diet before the onset of the dis-
ease. The fourth part contains questions about the course of
the disease, immediate treatment, postacute treatment, reha-
bilitation and other outpatient treatment. The fifth part of the
questionnaire contains the questions of related to the patient's
health condition at present, including mental health, satisfac-
tion with life, assessing the degree of addiction, lifestyle and
diet. At the end there is an open question, which constitutes
the patient to express his feelings, comments, etc., which
could not be divulged in the questionnaire questions. Com-
ments, suggestions and feelings to communicate both by the
patients and relatives, who were with a patient at home care
and home health care nurse who regularly visits the patient
and long-term home.
The patients are selected from a database Rehabilitation
Institute, praise, Prague, which is focused on patients after
stroke. The patients are moved to Rehabilitation Centre (RS)
for acute beds after the first attack of stroke, or from home to
after-care and rehabilitation (rehab) which is already at a
later stage. In this way we can gain valuable information
about the following services: information about the chain
postacute care-home care, secondary prevention (general
practitioner, specialist). During patient’s stay in the RS we
can detect contrast and continuity of care-postacute-acute
care, including widespread and specialized rehabilitation for
patients after stroke.
Conclusion
The treatment of acute stroke in the Czech Republic
may be on a bed of internal or neurological department. This
selection is determined by general medical conditions. The
network of stroke centers should be easily accessible to
every  patient. Timely transfer of  patients to the intensive
rehabilitation is limited by the capacity and their helth con-
dition. Intensive rehabilitation homes are often not able to
také care of more severely disabled patients (insufficient
number of nursing staff and failure to adapt the rehabilitation
program for elderly or severely disabled patients). Acute and
individual medicine in the Czech Republic is currently at the
same level as in EU countries. Preventive and risk factors of
control are not satisfactory. There are several reasons. Or-
ganization and coordination of services: primary care – acute
medicine – secondary care, do not usually work. The popu-
lation is not sufficiently informed about the importance of
prevention and control of risk factors. All these factors in-
crease the incidence of stroke. Sufficient long-term care and
rehabilitation, as well as well-coordinated secondary preven-
tion are often after hospitalization for acute bed. Prevention
and control of the determinants of health requires greater co-
operation and stronger social relations to economic and so-
cial factors of the disease. These parameters indicate that so-
cial cooperation in public and social policy is necessary for
effective results.
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